COMPARISON OF CLINICAL OUTCOMES BETWEEN RHEUMATOID ARTHRITIS PATIENTS UNDER TNF INHIBITORS USING A TAPERING STRATEGY OR STANDARD THERAPY REGIMEN IN DAILY CLINICAL PRACTICE

被引:0
|
作者
Plasencia, C. [1 ]
Wolbink, G. [2 ]
Krieckaert, C. [2 ]
Kneepkens, E. [2 ]
Turk, S. [2 ]
Bonilla, M. [1 ]
Villalba, A. [1 ]
Nurmohamed, M. [2 ]
Diego, C. [1 ]
Martin-Mola, E. [1 ]
Pascual-Salcedo, D. [1 ]
Balsa, A. [1 ]
机构
[1] La Paz Univ Hosp, Madrid, Spain
[2] Reade, Jan Van Breemen Res Inst, Amsterdam, Netherlands
关键词
D O I
10.1136/annrheumdis-2014-eular.2133
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
THU0157
引用
收藏
页码:234 / 234
页数:1
相关论文
共 50 条
  • [1] COMPARISON OF CLINICAL OUTCOMES BETWEEN SPONDYLOARTHRITIS PATIENTS TREATED WITH TNF INHIBITORS IN DAILY CLINICAL PRACTISE: TAPERING VERSUS STANDARD THERAPY
    Plasencia, C.
    Wolbink, G.
    Kneepkens, E.
    Krieckaert, C.
    l'Ami, M.
    Peiteado, D.
    Nuno, L.
    Arribas, F.
    Nurmohamed, M.
    Martin-Mola, E.
    Balsa, A.
    Pascual-Salcedo, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 713 - 713
  • [2] Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity
    Plasencia, C.
    Wolbink, G.
    Krieckaert, C. L. M.
    Kneepkens, E. L.
    Turk, S.
    Jurado, T.
    Martinez-Feito, A.
    Navarro-Compan, V.
    Bonilla, G.
    Villalba, A.
    Peiteado, D.
    Nuno, L.
    Martin-Mola, E.
    Nurmohamed, M. T.
    van der Kleij, D.
    Rispens, T.
    Pascual-Salcedo, D.
    Balsa, A.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 655 - 662
  • [3] Comparing a Tapering Strategy to the Standard Dosing Regimen of TNF Inhibitors in Patients with Rheumatoid Arthritis in Remission or with Low Disease Activity
    Plasencia-Rodriguez, Chamaida
    Wolbink, G. J.
    Krieckaert, Charlotte L. M.
    Kneepkens, Eva L.
    Turk, Samina
    Gema Bonilla, Maria
    Villalba, Alejandro
    Peiteado, Diana
    Nuno, Laura
    Nurmohamed, Mike T.
    Rispens, Theo
    van der Kleij, Desiree
    Jurado, Teresa
    Martin-Mola, Emilio
    Pascual-Salcedo, Dora
    Balsa, Alejandro
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1046 - S1046
  • [4] DRUG SURVIVAL OF TNF-α INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS IN DAILY CLINICAL PRACTICE: A RETROSPECTIVE COHORT RESEARCH
    Veenstra, Y.
    van der Horst, I. E.
    Becker, M. L.
    van Hall, O. N.
    ten Wolde, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1015 - 1015
  • [5] SAFETY OF JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CONDITIONS OF DAILY CLINICAL PRACTICE
    Cid Boza, Natalia
    Velloso Feijoo, M. L.
    Nahia, Plaza
    Luis Marenco, Jose
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1681 - 1682
  • [6] Cost-effectiveness of two TNF inhibitors, etanercept and infliximab, in patients with rheumatoid arthritis in daily clinical practice in the Netherlands
    Creemers, MC
    Kievit, W
    Flendrie, M
    Van den Hoogen, FH
    De Jong, AJ
    Van Riel, PL
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 430 - 430
  • [7] Improvement in health related quality of life of rheumatoid arthritis patients treated with TNF alpha inhibitors in daily clinical practice
    Kievit, W
    Welsing, PMJ
    Adang, EMM
    van Riel, PLCM
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 461 - 461
  • [8] Anti-TNFα therapy in a cohort of rheumatoid arthritis patients: Clinical outcomes
    Bazzani, Chiara
    Filippini, Matteo
    Caporali, Roberto
    Bobbio-Pallavicini, Francesca
    Favalli, Ennio Giulio
    Marchesoni, Antonio
    Atzeni, Fabiola
    Sarzi-Puttini, Piercarlo
    Gorla, Roberto
    [J]. AUTOIMMUNITY REVIEWS, 2009, 8 (03) : 260 - 265
  • [9] TNF-α Antagonist Survival Rate in a Cohort of Rheumatoid Arthritis Patients Observed under Conditions of Standard Clinical Practice
    Marchesoni, Antonio
    Zaccara, Eleonora
    Gorla, Roberto
    Bazzani, Chiara
    Sarzi-Puttini, Piercarlo
    Atzeni, Fabiola
    Caporali, Roberto
    Bobbio-Pallavicini, Francesca
    Favalli, Ennio Giulio
    [J]. CONTEMPORARY CHALLENGES IN AUTOIMMUNITY, 2009, 1173 : 837 - 846
  • [10] A cost-efficacy comparison of TNF inhibitors in rheumatoid arthritis based on actual dosing in clinical practice
    Chiou, C
    Wanke, LA
    Reyes, E
    Malone, DC
    Yu, EB
    Singh, A
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 282 - 282